Friday, January 4, 2013 (Last Updated: 01/07/2013)
Olivia S. Jung, from Harvard Business School in Boston, and colleagues conducted a qualitative research study involving 41 patients with clinically localized prostate cancer enrolled from the urology and radiology practices of the University of Pennsylvania. Participants completed a semi-structured interview and questionnaire discussing the burden of OOPE, its effect on treatment decisions, and prior knowledge of OOPE.
Based on qualitative assessment, the researchers identified five major themes: "my insurance takes care of it;" "health is more important than cost;" "I did not look into it;" "I cannot afford it but would have chosen the same treatment;" and "it is not my doctor's business." Ninety-three percent of patients reported that, even if they had known the actual OOPE of their treatment, they would not have chosen a different treatment. A socioeconomically heterogeneous group reported feeling burdened by OOPE, and their choice of treatment was unaffected. Before choosing their treatment, only two of the patients reported knowing a lot about the likely OOPE for different treatments.
"Among insured patients with prostate cancer treated at a large academic medical center, few had knowledge of OOPE before making treatment choices," the authors write.
OBGYN & Women's Health
Hematology & Oncology
Copyright © 2012 HealthDay. All rights reserved.